CAS 51953-13-0

2-Pyrimidinol

Description:

2-Pyrimidinol, with the CAS number 51953-13-0, is a heterocyclic organic compound characterized by a pyrimidine ring with a hydroxyl (-OH) group at the second position. This compound is a colorless to pale yellow solid that is soluble in water and polar organic solvents, reflecting its ability to engage in hydrogen bonding due to the presence of the hydroxyl group. 2-Pyrimidinol exhibits basic properties, typical of nitrogen-containing heterocycles, and can participate in various chemical reactions, including nucleophilic substitutions and condensation reactions. It is often utilized in the synthesis of pharmaceuticals and agrochemicals, owing to its role as a building block in the development of biologically active compounds. Additionally, its structural features allow it to act as a ligand in coordination chemistry. The compound's stability and reactivity can be influenced by the presence of substituents on the pyrimidine ring, making it a versatile intermediate in organic synthesis.

Formula: C₄H₄N₂O

Synonyms:

• 2-Pyrimidinol (7CI,9CI)

2-Pyrimidinol (7CI,9CI)

CAS: 51953-13-0

Formula: C₄H₄N₂O

Purity: 95%

Color and Shape: Solid

Molecular weight: 96.0874

Ref: IN-DA00DG0Y

2-Hydroxypyrimidine

CAS: 51953-13-0

2-Hydroxypyrimidine

Formula: C₄H₄N₂O

Purity: 97%

Color and Shape: light yellow crystalline solid

Molecular weight: 96.09g/mol

Ref: 54-OR5850

2-Pyrimidinol

CAS: 51953-13-0

2-Pyrimidinol is a sodium salt that is used as an antimicrobial agent. It has significant cytotoxicity against skin cancer cells and is also used to treat HIV infection. 2-Pyrimidinol inhibits the activity of inhibitor molecules, which are small molecules that inhibit the activity of important enzymes in cells. This inhibition results in increased production of ATP, which leads to cell death. 2-Pyrimidinol also binds to dna duplexes and prevents them from being opened by helicase, thus inhibiting cellular replication. The molecular structure of 2-pyrimidinol was determined using X-ray crystallography and molecular docking analysis. This compound has been shown to have a potential use in treating metabolic disorders due to its ability to inhibit glycolysis, or the breakdown of glucose, through competitive inhibition with phosphofructokinase (PFK).

Formula: C₄H₄N₂O

Purity: (%) Min. 98%

Color and Shape: Powder

Molecular weight: 96.09 g/mol

Ref: 3D-FP153543